溶栓
特奈特普酶
医学
冲程(发动机)
抗血栓
组织纤溶酶原激活剂
重症监护医学
纤溶剂
内科学
心脏病学
心肌梗塞
机械工程
工程类
出处
期刊:Continuum
[Lippincott Williams & Wilkins]
日期:2023-04-01
卷期号:29 (2): 425-442
被引量:26
标识
DOI:10.1212/con.0000000000001207
摘要
IV thrombolysis remains the most common acute stroke treatment. Advances in acting faster to treat stroke have increased its efficacy, and advances in imaging have expanded its use. However, implementing these advances and overcoming disparities in IV thrombolysis use remain major challenges.
科研通智能强力驱动
Strongly Powered by AbleSci AI